Anticardiolipin Antibodies and Recurrent Thromboembolism

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1997; 77(01): 221-222
DOI: 10.1055/s-0038-1655939

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Arnaud Rance

Service de Médecine vasculaire et Center Claude Berand de recherche sur les maladies vascularies, CHU Broussais, 96 rue Didot, 75674 Paris cedex 14, France
Jospeh Emmerich

Service de Médecine vasculaire et Center Claude Berand de recherche sur les maladies vascularies, CHU Broussais, 96 rue Didot, 75674 Paris cedex 14, France
Jean-Noël Fiessinger

Service de Médecine vasculaire et Center Claude Berand de recherche sur les maladies vascularies, CHU Broussais, 96 rue Didot, 75674 Paris cedex 14, France

Received 19 July 1996

Accepted after revision 16 September 1996

Publication Date:
11 July 2018 (online)

References
1 Prandoni P, Simioni P, Girolami A. Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thromb Haemost 1996; 75: 859

Reference Link Ris
PubMed Search in Google Scholar
2 Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Reber G, Arvieux J, Comby E, Degenne D, De MoerlooseP, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-452

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar